Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON45669Recruiting
Open-label, single-arm trial of clindamycin in bacterial disease, sponsored by Gelre ziekenhuizen. Primary endpoints: Population pharmacokinetic model, Clearance and 1 more. Started Jan 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON45669.